© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
August 18, 2022
Oyster Point Pharma Inc. announced that the largest Medicare pharmacy benefit manager in the United States will add its varenicline solution nasal spray for the treatment of dry eye.
August 09, 2022
A meta-analysis has found that depression and anxiety are significantly correlated with dry eye disease symptoms but not to dry eye disease signs.
A literature review finds that glaucoma care changed for the better during the COVID-19 pandemic.
August 08, 2022
New research examines the disparities in vision loss in glaucoma cases.
August 04, 2022
Cimerli can be used for all 5 indications. No information on pricing has been released.
July 28, 2022
Oyster Point Pharma Inc. this week announced the expansion of patient access to varenicline solution (Tyrvaya) nasal spray.
July 26, 2022
Research examines whether a step-approach with treatment for macular edema produces positive results.
July 19, 2022
The pipeline for eye health is full of potential therapies. Here's a look at 4 that may be available in the near future.
July 14, 2022
The price of the biosimilar may also be persuasive for patients.
July 13, 2022
The drug is a potential new therapy for dry eye disease with a novel mechanism of action.